
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>record_id</th><th>visit</th><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>BS15024</td><td>1</td><td>Acetylsalicylic acid</td><td>Bisoprolol</td><td>Acetylsalicylic acid may decrease the antihypertensive activities of Bisoprolol.</td></tr><tr><td>BS15024</td><td>1</td><td>Beclomethasone dipropionate</td><td>Acetylsalicylic acid</td><td>The risk or severity of adverse effects can be increased when Beclomethasone
dipropionate is combined with Acetylsalicylic acid.</td></tr><tr><td>BS15024</td><td>1</td><td>Beclomethasone dipropionate</td><td>Atorvastatin</td><td>The metabolism of Atorvastatin can be increased when combined with
Beclomethasone dipropionate.</td></tr><tr><td>BS15024</td><td>1</td><td>Beclomethasone dipropionate</td><td>Cobicistat</td><td>The metabolism of Cobicistat can be increased when combined with Beclomethasone
dipropionate.</td></tr><tr><td>BS15024</td><td>1</td><td>Beclomethasone dipropionate</td><td>Dapagliflozin</td><td>The risk or severity of hyperglycemia can be increased when Beclomethasone
dipropionate is combined with Dapagliflozin.</td></tr><tr><td>BS15024</td><td>1</td><td>Beclomethasone dipropionate</td><td>Dolutegravir</td><td>Beclomethasone dipropionate may decrease the excretion rate of Dolutegravir
which could result in a higher serum level.</td></tr><tr><td>BS15024</td><td>1</td><td>Beclomethasone dipropionate</td><td>Valsartan</td><td>The excretion of Valsartan can be decreased when combined with Beclomethasone
dipropionate.</td></tr><tr><td>BS15024</td><td>1</td><td>Canrenone</td><td>Acetylsalicylic acid</td><td>Acetylsalicylic acid may decrease the excretion rate of Canrenone which could
result in a higher serum level.</td></tr><tr><td>BS15024</td><td>1</td><td>Canrenone</td><td>Bisoprolol</td><td>The risk or severity of hyperkalemia can be increased when Bisoprolol is
combined with Canrenone.</td></tr><tr><td>BS15024</td><td>1</td><td>Canrenone</td><td>Sacubitril</td><td>Canrenone may increase the excretion rate of Sacubitril which could result in a
lower serum level and potentially a reduction in efficacy.</td></tr><tr><td>BS15024</td><td>1</td><td>Cobicistat</td><td>Atorvastatin</td><td>The serum concentration of Atorvastatin can be increased when it is combined
with Cobicistat.</td></tr><tr><td>BS15024</td><td>1</td><td>Cobicistat</td><td>Bisoprolol</td><td>The serum concentration of Bisoprolol can be increased when it is combined with
Cobicistat.</td></tr><tr><td>BS15024</td><td>1</td><td>Cobicistat</td><td>Formoterol</td><td>The metabolism of Formoterol can be decreased when combined with Cobicistat.</td></tr><tr><td>BS15024</td><td>1</td><td>Codeine</td><td>Canrenone</td><td>The therapeutic efficacy of Canrenone can be decreased when used in combination
with Codeine.</td></tr><tr><td>BS15024</td><td>1</td><td>Codeine</td><td>Cobicistat</td><td>The metabolism of Codeine can be decreased when combined with Cobicistat.</td></tr><tr><td>BS15024</td><td>1</td><td>Codeine</td><td>Formoterol</td><td>The risk or severity of adverse effects can be increased when Codeine is
combined with Formoterol.</td></tr><tr><td>BS15024</td><td>1</td><td>Codeine</td><td>Lansoprazole</td><td>The metabolism of Codeine can be decreased when combined with Lansoprazole.</td></tr><tr><td>BS15024</td><td>1</td><td>Dapagliflozin</td><td>Acetylsalicylic acid</td><td>The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid
is combined with Dapagliflozin.</td></tr><tr><td>BS15024</td><td>1</td><td>Dapagliflozin</td><td>Bisoprolol</td><td>The therapeutic efficacy of Dapagliflozin can be increased when used in
combination with Bisoprolol.</td></tr><tr><td>BS15024</td><td>1</td><td>Dapagliflozin</td><td>Sacubitril</td><td>The risk or severity of adverse effects can be increased when Dapagliflozin is
combined with Sacubitril.</td></tr><tr><td>BS15024</td><td>1</td><td>Darunavir</td><td>Atorvastatin</td><td>The metabolism of Atorvastatin can be decreased when combined with Darunavir.</td></tr><tr><td>BS15024</td><td>1</td><td>Darunavir</td><td>Beclomethasone dipropionate</td><td>The metabolism of Beclomethasone dipropionate can be decreased when combined
with Darunavir.</td></tr><tr><td>BS15024</td><td>1</td><td>Darunavir</td><td>Bisoprolol</td><td>The metabolism of Bisoprolol can be decreased when combined with Darunavir.</td></tr><tr><td>BS15024</td><td>1</td><td>Darunavir</td><td>Codeine</td><td>The metabolism of Codeine can be decreased when combined with Darunavir.</td></tr><tr><td>BS15024</td><td>1</td><td>Darunavir</td><td>Dapagliflozin</td><td>The therapeutic efficacy of Dapagliflozin can be decreased when used in
combination with Darunavir.</td></tr><tr><td>BS15024</td><td>1</td><td>Darunavir</td><td>Dolutegravir</td><td>The serum concentration of Dolutegravir can be increased when it is combined
with Darunavir.</td></tr><tr><td>BS15024</td><td>1</td><td>Darunavir</td><td>Formoterol</td><td>The metabolism of Formoterol can be decreased when combined with Darunavir.</td></tr><tr><td>BS15024</td><td>1</td><td>Darunavir</td><td>Lansoprazole</td><td>The metabolism of Lansoprazole can be decreased when combined with Darunavir.</td></tr><tr><td>BS15024</td><td>1</td><td>Darunavir</td><td>Valsartan</td><td>The excretion of Valsartan can be decreased when combined with Darunavir.</td></tr><tr><td>BS15024</td><td>1</td><td>Dolutegravir</td><td>Bisoprolol</td><td>The serum concentration of Dolutegravir can be increased when it is combined
with Bisoprolol.</td></tr><tr><td>BS15024</td><td>1</td><td>Dolutegravir</td><td>Cobicistat</td><td>Cobicistat may decrease the excretion rate of Dolutegravir which could result in
a higher serum level.</td></tr><tr><td>BS15024</td><td>1</td><td>Dolutegravir</td><td>Lansoprazole</td><td>Lansoprazole may decrease the excretion rate of Dolutegravir which could result
in a higher serum level.</td></tr><tr><td>BS15024</td><td>1</td><td>Formoterol</td><td>Acetylsalicylic acid</td><td>The risk or severity of hypertension can be increased when Acetylsalicylic acid
is combined with Formoterol.</td></tr><tr><td>BS15024</td><td>1</td><td>Formoterol</td><td>Bisoprolol</td><td>The therapeutic efficacy of Formoterol can be decreased when used in combination
with Bisoprolol.</td></tr><tr><td>BS15024</td><td>1</td><td>Lansoprazole</td><td>Acetylsalicylic acid</td><td>The metabolism of Acetylsalicylic acid can be decreased when combined with
Lansoprazole.</td></tr><tr><td>BS15024</td><td>1</td><td>Lansoprazole</td><td>Atorvastatin</td><td>The metabolism of Atorvastatin can be decreased when combined with Lansoprazole.</td></tr><tr><td>BS15024</td><td>1</td><td>Lansoprazole</td><td>Formoterol</td><td>The metabolism of Formoterol can be decreased when combined with Lansoprazole.</td></tr><tr><td>BS15024</td><td>1</td><td>Prasugrel</td><td>Acetylsalicylic acid</td><td>Acetylsalicylic acid may increase the antiplatelet activities of Prasugrel.</td></tr><tr><td>BS15024</td><td>1</td><td>Prasugrel</td><td>Bisoprolol</td><td>Bisoprolol may decrease the excretion rate of Prasugrel which could result in a
higher serum level.</td></tr><tr><td>BS15024</td><td>1</td><td>Prasugrel</td><td>Canrenone</td><td>Canrenone may increase the excretion rate of Prasugrel which could result in a
lower serum level and potentially a reduction in efficacy.</td></tr><tr><td>BS15024</td><td>1</td><td>Prasugrel</td><td>Formoterol</td><td>The metabolism of Prasugrel can be decreased when combined with Formoterol.</td></tr><tr><td>BS15024</td><td>1</td><td>Prasugrel</td><td>Lansoprazole</td><td>The metabolism of Prasugrel can be decreased when combined with Lansoprazole.</td></tr><tr><td>BS15024</td><td>1</td><td>Prasugrel</td><td>Sacubitril</td><td>Prasugrel may decrease the excretion rate of Sacubitril which could result in a
higher serum level.</td></tr><tr><td>BS15024</td><td>1</td><td>Sacubitril</td><td>Acetylsalicylic acid</td><td>The risk or severity of angioedema can be increased when Acetylsalicylic acid is
combined with Sacubitril.</td></tr><tr><td>BS15024</td><td>1</td><td>Sacubitril</td><td>Atorvastatin</td><td>The excretion of Atorvastatin can be decreased when combined with Sacubitril.</td></tr><tr><td>BS15024</td><td>1</td><td>Sacubitril</td><td>Bisoprolol</td><td>The risk or severity of adverse effects can be increased when Bisoprolol is
combined with Sacubitril.</td></tr><tr><td>BS15024</td><td>1</td><td>Valsartan</td><td>Acetylsalicylic acid</td><td>The risk or severity of renal failure, hyperkalemia, and hypertension can be
increased when Valsartan is combined with Acetylsalicylic acid.</td></tr><tr><td>BS15024</td><td>1</td><td>Valsartan</td><td>Atorvastatin</td><td>The excretion of Atorvastatin can be decreased when combined with Valsartan.</td></tr><tr><td>BS15024</td><td>1</td><td>Valsartan</td><td>Bisoprolol</td><td>Valsartan may increase the hypotensive activities of Bisoprolol.</td></tr><tr><td>BS15024</td><td>1</td><td>Valsartan</td><td>Canrenone</td><td>The risk or severity of hyperkalemia can be increased when Valsartan is combined
with Canrenone.</td></tr><tr><td>BS15024</td><td>1</td><td>Valsartan</td><td>Cobicistat</td><td>The excretion of Valsartan can be decreased when combined with Cobicistat.</td></tr><tr><td>BS15024</td><td>1</td><td>Valsartan</td><td>Dapagliflozin</td><td>The risk or severity of adverse effects can be increased when Valsartan is
combined with Dapagliflozin.</td></tr><tr><td>BS15024</td><td>1</td><td>Valsartan</td><td>Formoterol</td><td>The metabolism of Formoterol can be decreased when combined with Valsartan.</td></tr><tr><td>BS15024</td><td>1</td><td>Valsartan</td><td>Lansoprazole</td><td>The metabolism of Lansoprazole can be decreased when combined with Valsartan.</td></tr><tr><td>BS15024</td><td>1</td><td>Valsartan</td><td>Prasugrel</td><td>The metabolism of Prasugrel can be decreased when combined with Valsartan.</td></tr></tbody></table></div>
